Results from a clinical trial conducted by researchers at the National Institutes of Health (NIH) show that people with low-grade lymphomatoid granulomatosis who are treated with interferon alfa-2b, a type of immunotherapy, can live for decades after diagnosis.Lymphomatoid granulomatosis is a rare precancerous condition triggered by Epstein-Barr virus infection.
#people #back #years #information #potentially #researchers #participants #dramatically #side-effects #infectious-diseases
[
add
]
[
|
|
...
]